TP53 and chronic obstructive pulmonary disease: Transcriptomic Analysis was performed to investigate the transcriptional changes in CSE-induced BEAS-2B cells.<h4>Results</h4>Kaempferol is a key compound of YFN, and STAT3, TP53, and IL1B are predicted to be the core targets of YFN for COPD treatment.